SPOTLIGHT -
The Psychiatric Times editor-in-chief shares perspectives on how a novel treatment, MDMA-assisted therapy, can potentially change the treatment landscape and improve patients’ lives.
Psychiatry’s Risky Gamble on Recreational Drugs: The Royal Road to the Unconscious or Down a Pharmacologic Garden Path
David Hellerstein, MD: Psychedelic Treatments for Psychiatric Disorders
The Anniversary of 9/11 Research Roundup
Anne Marie Albano, PhD: A Conversation on the Spectrum of Anxiety
Addressing Alcohol or Cannabis Use in Patients With Anxiety Disorders
Exploring the Misuse of PTSD Diagnosis